Related Experiment Videos
Pharmacologic considerations in the neonate with congenital heart disease
1Department of Pharmacy Practice, Temple University School of Pharmacy, Philadelphia, Pennsylvania, USA. caligaro@astro.temple.edu
Insights
Newer medications improve outcomes for infants with congenital heart disease. Understanding pharmacologic effects and pharmacokinetics optimizes treatment for cardiac failure and arrhythmias, enhancing survival rates.
Area of Science:
- Pediatric Cardiology
- Pharmacology
- Physiology
Background:
- Congenital heart disease (CHD) presents unique challenges in infant cardiovascular development.
- Understanding compensatory physiological changes is crucial for managing cardiac complications in infants with CHD.
Purpose of the Study:
- To review advances in managing cardiac failure and arrhythmias in infants with CHD.
- To highlight the role of newer pharmacologic agents in improving outcomes for pediatric cardiovascular conditions.
Main Methods:
- Literature review of recent advancements in pediatric cardiology.
- Analysis of pharmacologic data including effects, pharmacokinetics, and pharmacodynamics of relevant medications.
Main Results:
- Newer therapeutic approaches have emerged for managing cardiac failure and arrhythmias in infants with CHD.
- Improved understanding of drug actions leads to more precise medication use.
Conclusions:
- Appropriate use of newer pharmacologic agents can significantly prolong survival in infants with CHD.
- Enhanced knowledge of cardiovascular development and compensatory mechanisms improves patient outcomes.
Abstract:
Advances in knowledge about the developing cardiovascular system and compensatory physiologic changes that occur in infants with congenital heart disease have led to new approaches in the management of cardiac failure and arrhythmias. Information about the pharmacologic effects, pharmacokinetics, and pharmacodynamics of newer agents used in the management of congenital heart disease have led to more appropriate use of these medications to prolong survival and improve outcomes.